Sebastien Bonnet

Sebastien Bonnet

Université Laval

H-index: 70

North America-Canada

About Sebastien Bonnet

Sebastien Bonnet, With an exceptional h-index of 70 and a recent h-index of 52 (since 2020), a distinguished researcher at Université Laval, specializes in the field of Pulmonary hypertension and vascular biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries

Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities

Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking

Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension

VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS

ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic Reprograming.

Right Ventricle and Epigenetics: A Systematic Review

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

Sebastien Bonnet Information

University

Position

Professor Canada

Citations(all)

30185

Citations(since 2020)

21305

Cited By

13440

hIndex(all)

70

hIndex(since 2020)

52

i10Index(all)

145

i10Index(since 2020)

118

Email

University Profile Page

Google Scholar

Sebastien Bonnet Skills & Research Interests

Pulmonary hypertension and vascular biology

Top articles of Sebastien Bonnet

Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries

2024/3/19

Sebastien Bonnet
Sebastien Bonnet

H-Index: 45

Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities

2024/3/1

Sebastien Bonnet
Sebastien Bonnet

H-Index: 45

Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking

American Journal of Respiratory Cell and Molecular Biology

2024/2

Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension

American Journal of Respiratory and Critical Care Medicine

2024/1/23

VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS

European Respiratory Journal

2024/1/1

ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic Reprograming.

bioRxiv

2024

Nicolas Flamand
Nicolas Flamand

H-Index: 20

Sebastien Bonnet
Sebastien Bonnet

H-Index: 45

Right Ventricle and Epigenetics: A Systematic Review

2023/11/23

Sebastien Bonnet
Sebastien Bonnet

H-Index: 45

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

Genetics in Medicine

2023/11/1

Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension

Nature cardiovascular research

2023/10

Emergence of disease-specific endothelial and stromal cell populations responsible for arterial remodeling during development of pulmonary arterial hypertension

bioRxiv

2023/9/6

Patients’ perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy

thorax

2023/7/1

Targeting Wnt-ß-catenin-FOSL signaling ameliorates right ventricular remodeling

Circulation Research

2023/5/26

Astrid Weiss
Astrid Weiss

H-Index: 22

Sebastien Bonnet
Sebastien Bonnet

H-Index: 45

The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets

2023/5/12

G9a/GLP targeting ameliorates pulmonary vascular remodeling in pulmonary arterial hypertension

American Journal of Respiratory Cell and Molecular Biology

2023/5

Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH

Revue des Maladies Respiratoires

2023/11/1

DNA–Protein Kinase Catalytic Subunit as a Potential Target for Pulmonary Arterial Hypertension

American Journal of Respiratory Cell and Molecular Biology

2023/1

Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension

Nature cardiovascular research

2022/8

Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension

Science Translational Medicine

2022/6/8

BET protein inhibition for pulmonary arterial hypertension: a pilot clinical trial

American Journal of Respiratory and Critical Care Medicine

2022/6/1

Jason Weatherald
Jason Weatherald

H-Index: 17

Sebastien Bonnet
Sebastien Bonnet

H-Index: 45

The latest in animal models of pulmonary hypertension and right ventricular failure

2022/4/29

Sebastien Bonnet
Sebastien Bonnet

H-Index: 45

See List of Professors in Sebastien Bonnet University(Université Laval)

Co-Authors

academic-engine